[3rd generation ABL kinase inhibitor and Philadelphia chromosome positive leukemia].
Tetsuzo
T
Tauchi
D000818:Animals; D002986:Clinical Trials as Topic; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D007093:Imidazoles / Q000737:chemistry / Q000627:therapeutic use; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome / Q000187:drug effects*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011724:Pyridazines / Q000737:chemistry / Q000627:therapeutic use
D007093:Imidazoles; D047428:Protein Kinase Inhibitors; D011724:Pyridazines; C545373:ponatinib; D016044:Fusion Proteins, bcr-abl